Search for other papers by Giulia Bresciani in
Google Scholar
PubMed
Search for other papers by Angeliki Ditsiou in
Google Scholar
PubMed
Search for other papers by Chiara Cilibrasi in
Google Scholar
PubMed
Search for other papers by Viviana Vella in
Google Scholar
PubMed
Search for other papers by Federico Rea in
Google Scholar
PubMed
Search for other papers by Marco Schiavon in
Google Scholar
PubMed
Search for other papers by Narciso Giorgio Cavallesco in
Google Scholar
PubMed
Search for other papers by Georgios Giamas in
Google Scholar
PubMed
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Teresa Gagliano in
Google Scholar
PubMed
broncho-pulmonary NENs (BP-NENs) and represents approximately 25/30% of all NENs with an incidence of 1.2/100,000 people/year in European countries ( 5 ). The World Health Organization defines BP-NENs as an heterogeneous group that ranges from well
Search for other papers by Erik Rösner in
Google Scholar
PubMed
Search for other papers by Daniel Kaemmerer in
Google Scholar
PubMed
Search for other papers by Elisa Neubauer in
Google Scholar
PubMed
Search for other papers by Jörg Sänger in
Google Scholar
PubMed
Search for other papers by Amelie Lupp in
Google Scholar
PubMed
most often found in the gastrointestinal tract or the lung. Bronchopulmonary NEN (BP-NEN) are classified into low-grade, well-differentiated typical carcinoids (TC), intermediate-grade atypical carcinoids (AC) and high-grade, poorly differentiated